Global Leukapheresis Market Size, Status and Forecast 2018-2025


Report ID : RNR-224432 Category : Pharma Healthcare Published Date : 2018
Publisher : QYResearch Pages : 124 Format : PDF
This report focuses on the global Leukapheresis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Leukapheresis development in United States, Europe and China.
Leukapheresis is a laboratory procedure in which white blood cells are separated from a sample of blood. It is a specific type of apheresis, the more general term for separating out one particular constituent of blood and returning the remainder to the circulation.

Leukapheresis may be performed to decrease a very high white blood cell count, to obtain autologous (i.e., the patient's own) blood cells for later transplant back into the patient, or to obtain cells for research purposes.

In 2017, the global Leukapheresis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study

    Asahi Kasei Medical

    Fresenius

    Haemonetics

    Terumo BCT

    STEMCELL Technologies

    Macopharma

    HemaCare

    AllCells

    StemExpress

    Caltag Medsystem

    ZenBio

Market segment by Type, the product can be split into

    Apheresis Machine

    Leukocyte Filter

    Column

    Disposables

Market segment by Application, split into

    Hospitals

    Research Institute

Market segment by Regions/Countries, this report covers

    United States

    Europe

    China

    Japan

    Southeast Asia

    India

    Central & South America

The study objectives of this report are:

    To analyze global Leukapheresis status, future forecast, growth opportunity, key market and key players.

    To present the Leukapheresis development in United States, Europe and China.

    To strategically profile the key players and comprehensively analyze their development plan and strategies.

    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Leukapheresis are as follows:

    History Year: 2013-2017

    Base Year: 2017

    Estimated Year: 2018

    Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview

    1.1 Study Scope

    1.2 Key Market Segments

    1.3 Players Covered

    1.4 Market Analysis by Type

        1.4.1 Global Leukapheresis Market Size Growth Rate by Type (2013-2025)

        1.4.2 Apheresis Machine

        1.4.3 Leukocyte Filter

        1.4.4 Column

        1.4.5 Disposables

    1.5 Market by Application

        1.5.1 Global Leukapheresis Market Share by Application (2013-2025)

        1.5.2 Hospitals

        1.5.3 Research Institute

    1.6 Study Objectives

    1.7 Years Considered

2 Global Growth Trends

    2.1 Leukapheresis Market Size

    2.2 Leukapheresis Growth Trends by Regions

        2.2.1 Leukapheresis Market Size by Regions (2013-2025)

        2.2.2 Leukapheresis Market Share by Regions (2013-2018)

    2.3 Industry Trends

        2.3.1 Market Top Trends

        2.3.2 Market Drivers

        2.3.3 Market Opportunities

3 Market Share by Key Players

    3.1 Leukapheresis Market Size by Manufacturers

        3.1.1 Global Leukapheresis Revenue by Manufacturers (2013-2018)

        3.1.2 Global Leukapheresis Revenue Market Share by Manufacturers (2013-2018)

        3.1.3 Global Leukapheresis Market Concentration Ratio (CR5 and HHI)

    3.2 Leukapheresis Key Players Head office and Area Served

    3.3 Key Players Leukapheresis Product/Solution/Service

    3.4 Date of Enter into Leukapheresis Market

    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

    4.1 Global Leukapheresis Market Size by Type (2013-2018)

    4.2 Global Leukapheresis Market Size by Application (2013-2018)

5 United States

    5.1 United States Leukapheresis Market Size (2013-2018)

    5.2 Leukapheresis Key Players in United States

    5.3 United States Leukapheresis Market Size by Type

    5.4 United States Leukapheresis Market Size by Application

6 Europe

    6.1 Europe Leukapheresis Market Size (2013-2018)

    6.2 Leukapheresis Key Players in Europe

    6.3 Europe Leukapheresis Market Size by Type

    6.4 Europe Leukapheresis Market Size by Application

7 China

    7.1 China Leukapheresis Market Size (2013-2018)

    7.2 Leukapheresis Key Players in China

    7.3 China Leukapheresis Market Size by Type

    7.4 China Leukapheresis Market Size by Application

8 Japan

    8.1 Japan Leukapheresis Market Size (2013-2018)

    8.2 Leukapheresis Key Players in Japan

    8.3 Japan Leukapheresis Market Size by Type

    8.4 Japan Leukapheresis Market Size by Application

9 Southeast Asia

    9.1 Southeast Asia Leukapheresis Market Size (2013-2018)

    9.2 Leukapheresis Key Players in Southeast Asia

    9.3 Southeast Asia Leukapheresis Market Size by Type

    9.4 Southeast Asia Leukapheresis Market Size by Application

10 India

    10.1 India Leukapheresis Market Size (2013-2018)

    10.2 Leukapheresis Key Players in India

    10.3 India Leukapheresis Market Size by Type

    10.4 India Leukapheresis Market Size by Application

11 Central & South America

    11.1 Central & South America Leukapheresis Market Size (2013-2018)

    11.2 Leukapheresis Key Players in Central & South America

    11.3 Central & South America Leukapheresis Market Size by Type

    11.4 Central & South America Leukapheresis Market Size by Application

12 International Players Profiles

    12.1 Asahi Kasei Medical

        12.1.1 Asahi Kasei Medical Company Details

        12.1.2 Company Description and Business Overview

        12.1.3 Leukapheresis Introduction

        12.1.4 Asahi Kasei Medical Revenue in Leukapheresis Business (2013-2018)

        12.1.5 Asahi Kasei Medical Recent Development

    12.2 Fresenius

        12.2.1 Fresenius Company Details

        12.2.2 Company Description and Business Overview

        12.2.3 Leukapheresis Introduction

        12.2.4 Fresenius Revenue in Leukapheresis Business (2013-2018)

        12.2.5 Fresenius Recent Development

    12.3 Haemonetics

        12.3.1 Haemonetics Company Details

        12.3.2 Company Description and Business Overview

        12.3.3 Leukapheresis Introduction

        12.3.4 Haemonetics Revenue in Leukapheresis Business (2013-2018)

        12.3.5 Haemonetics Recent Development

    12.4 Terumo BCT

        12.4.1 Terumo BCT Company Details

        12.4.2 Company Description and Business Overview

        12.4.3 Leukapheresis Introduction

        12.4.4 Terumo BCT Revenue in Leukapheresis Business (2013-2018)

        12.4.5 Terumo BCT Recent Development

    12.5 STEMCELL Technologies

        12.5.1 STEMCELL Technologies Company Details

        12.5.2 Company Description and Business Overview

        12.5.3 Leukapheresis Introduction

        12.5.4 STEMCELL Technologies Revenue in Leukapheresis Business (2013-2018)

        12.5.5 STEMCELL Technologies Recent Development

    12.6 Macopharma

        12.6.1 Macopharma Company Details

        12.6.2 Company Description and Business Overview

        12.6.3 Leukapheresis Introduction

        12.6.4 Macopharma Revenue in Leukapheresis Business (2013-2018)

        12.6.5 Macopharma Recent Development

    12.7 HemaCare

        12.7.1 HemaCare Company Details

        12.7.2 Company Description and Business Overview

        12.7.3 Leukapheresis Introduction

        12.7.4 HemaCare Revenue in Leukapheresis Business (2013-2018)

        12.7.5 HemaCare Recent Development

    12.8 AllCells

        12.8.1 AllCells Company Details

        12.8.2 Company Description and Business Overview

        12.8.3 Leukapheresis Introduction

        12.8.4 AllCells Revenue in Leukapheresis Business (2013-2018)

        12.8.5 AllCells Recent Development

    12.9 StemExpress

        12.9.1 StemExpress Company Details

        12.9.2 Company Description and Business Overview

        12.9.3 Leukapheresis Introduction

        12.9.4 StemExpress Revenue in Leukapheresis Business (2013-2018)

        12.9.5 StemExpress Recent Development

    12.10 Caltag Medsystem

        12.10.1 Caltag Medsystem Company Details

        12.10.2 Company Description and Business Overview

        12.10.3 Leukapheresis Introduction

        12.10.4 Caltag Medsystem Revenue in Leukapheresis Business (2013-2018)

        12.10.5 Caltag Medsystem Recent Development

    12.11 ZenBio

13 Market Forecast 2018-2025

    13.1 Market Size Forecast by Regions

    13.2 United States

    13.3 Europe

    13.4 China

    13.5 Japan

    13.6 Southeast Asia

    13.7 India

    13.8 Central & South America

    13.9 Market Size Forecast by Product (2018-2025)

    13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

    15.1 Research Methodology

        15.1.1 Methodology/Research Approach

            15.1.1.1 Research Programs/Design

            15.1.1.2 Market Size Estimation

            12.1.1.3 Market Breakdown and Data Triangulation

        15.1.2 Data Source

            15.1.2.1 Secondary Sources

            15.1.2.2 Primary Sources

    15.2 Disclaimer

    15.3 Author Details